Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Poly (A) Click-seq for U937 control and PMA-treated (6h and 24h) cells

ABSTRACT: Poly(A)-ClickSeq: click-chemistry for next-generation 3'-end sequencing without RNA enrichment or fragmentation enabling simultaneous genomewide poly(A)-site identification and differential expression analysis

ORGANISM(S): Homo sapiens

PROVIDER: GSE169140 | GEO | 2023/01/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 2]

Project description:The success of targeted therapies hinges on our ability to understand the molecular and cellular mechanism of action of these agents. Here we modify various BET bromodomain inhibitors, an exemplar novel targeted therapy, to create functionally conserved compounds that are amenable to click-chemistry and can be used as molecular probes in vitro and in vivo. Using click-proteomics and click-sequencing we provide new mechanistic insights to explain the gene regulatory function of BRD4 and the transcriptional changes invoked by BET inhibitors. In mouse models of acute leukaemia, we use high resolution microscopy and flow cytometry to highlight the underappreciated heterogeneity of drug activity within tumour cells located in different tissue compartments. We also demonstrate the differential distribution and effects of the drug in normal and malignant cells in vivo. These data provide critical insights that reveal the cellular and molecular details for the efficacy and limitations of these agents. This study provides a framework for the pre-clinical assessment of other conventional and targeted therapies.

2017-07-13 | GSE88749 | GEO

Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 1]

2017-07-13 | GSE88748 | GEO

Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies

Project description:Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies

| PRJNA348447 | ENA

Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq]

2017-07-13 | GSE88750 | GEO

Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [ChIP-seq 2]

2017-07-13 | GSE88747 | GEO

Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [ChIP-seq 1]

2017-07-13 | GSE88746 | GEO

Impact of azide metabolic glycoengineering and bioorthogonal click chemistry cell-cell tethering in adipose tissue-derived mesenchymal stromal cells

Project description:We report RNA sequencing data from adipose tissue-derived mesenchymal stromal cells (hASCs) functionalized via metabolic glycoengineering with pendant azide sialosides. Beyond the impact of this cell surface engineering on transcriptome, we explore the expression profiles of azide-hASCs covalently tethered to an interfacial glycosaminoglycan via bioorthogonal click chemistry and yielding a 3D multicellular construct. We find global gene expression changes in response to metabolic glycoengineering in 2D cell culture conditions as well as those arising from cell-to-cell tethering into 3D environments.

2024-04-15 | GSE231507 | GEO

Profiling of chromatin deposition bias in RPE-1 cells using Double-click-seq

Project description:We used double-click-seq method to profile chromatin deposition bias in RPE-1 cells. Untreated wild-type, p53 knock-out and several treatments (hydroxyurea, ATR inhibitor, curaxin) and their combinations were profiled for characterizing assymetry during DNA replication.

2021-10-04 | E-MTAB-8624 | biostudies-arrayexpress

Homo sapiens

Project description:Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 2]

| PRJNA348452 | ENA

Homo sapiens

Project description:Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 1]

| PRJNA348450 | ENA